Vikas Lifecare Limited (BOM:542655)
India · Delayed Price · Currency is INR 1.640
+0.010 (0.61%)
At close: Apr 21, 2026
Vikas Lifecare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 4,659 | 4,800 | 4,457 | 4,760 | 3,009 | 749.95 |
Other Revenue | 1,300 | 0 | - | - | 0 | - |
| 5,959 | 4,800 | 4,457 | 4,760 | 3,009 | 749.95 | |
Revenue Growth (YoY) | 30.18% | 7.69% | -6.37% | 58.20% | 301.26% | -51.98% |
Cost of Revenue | 4,518 | 4,653 | 4,195 | 4,522 | 2,909 | 637.73 |
Gross Profit | 1,442 | 147.11 | 262.04 | 238.39 | 99.76 | 112.22 |
Selling, General & Admin | 48.23 | 48.88 | 67.8 | 35.2 | 21.27 | 8.03 |
Other Operating Expenses | 296.66 | 100.88 | 141.93 | 78.73 | 72.69 | 22.22 |
Operating Expenses | 410.93 | 217.12 | 246.19 | 144.03 | 109.08 | 37.09 |
Operating Income | 1,031 | -70.01 | 15.85 | 94.36 | -9.32 | 75.13 |
Interest Expense | -63.17 | -44.66 | -27.02 | -23.02 | -13.77 | -38.79 |
Interest & Investment Income | 34.13 | 34.13 | 5.22 | 9.34 | 5.91 | 2.4 |
Earnings From Equity Investments | -1,346 | -59.19 | -4.98 | 0.42 | 0.3 | 1.93 |
Currency Exchange Gain (Loss) | 50.3 | 50.3 | 1.76 | 9.84 | 5.97 | 1.52 |
Other Non Operating Income (Expenses) | 59.85 | 59.85 | -1.46 | 6.43 | -7.4 | -14.7 |
EBT Excluding Unusual Items | -234.59 | -29.59 | -10.63 | 97.37 | -18.3 | 27.49 |
Gain (Loss) on Sale of Investments | -96.7 | -96.7 | 242.11 | -311.1 | 409.15 | - |
Gain (Loss) on Sale of Assets | -2.41 | -2.41 | 3.22 | 0.06 | 0.01 | - |
Other Unusual Items | - | - | -63.88 | - | - | -42.49 |
Pretax Income | -333.7 | -128.69 | 170.83 | -213.67 | 390.86 | -15 |
Income Tax Expense | -73.13 | -19.54 | 36.29 | -58.57 | 101.39 | 20.02 |
Earnings From Continuing Operations | -260.56 | -109.15 | 134.54 | -155.1 | 289.47 | -35.02 |
Minority Interest in Earnings | -0.06 | 3.01 | 5.75 | 2.11 | -2.48 | - |
Net Income | -260.62 | -106.14 | 140.29 | -152.99 | 286.99 | -35.02 |
Net Income to Common | -260.62 | -106.14 | 140.29 | -152.99 | 286.99 | -35.02 |
Shares Outstanding (Basic) | 393 | 1,839 | 1,474 | 1,306 | 934 | 664 |
Shares Outstanding (Diluted) | 393 | 1,839 | 1,530 | 1,306 | 934 | 664 |
Shares Change (YoY) | - | 20.17% | 17.18% | 39.77% | 40.83% | 0.00% |
EPS (Basic) | -0.66 | -0.06 | 0.10 | -0.12 | 0.31 | -0.05 |
EPS (Diluted) | -0.67 | -0.06 | 0.09 | -0.12 | 0.31 | -0.05 |
Free Cash Flow | - | -2,349 | -577.2 | -1,300 | -166.09 | -91.58 |
Free Cash Flow Per Share | - | -1.28 | -0.38 | -0.99 | -0.18 | -0.14 |
Gross Margin | 24.19% | 3.06% | 5.88% | 5.01% | 3.31% | 14.96% |
Operating Margin | 17.30% | -1.46% | 0.36% | 1.98% | -0.31% | 10.02% |
Profit Margin | -4.37% | -2.21% | 3.15% | -3.21% | 9.54% | -4.67% |
Free Cash Flow Margin | - | -48.94% | -12.95% | -27.31% | -5.52% | -12.21% |
EBITDA | 1,121 | -2.66 | 52.31 | 124.46 | 3.39 | 81.97 |
EBITDA Margin | 18.82% | -0.06% | 1.17% | 2.61% | 0.11% | 10.93% |
D&A For EBITDA | 90.52 | 67.35 | 36.46 | 30.09 | 12.72 | 6.84 |
EBIT | 1,031 | -70.01 | 15.85 | 94.36 | -9.32 | 75.13 |
EBIT Margin | 17.30% | -1.46% | 0.36% | 1.98% | -0.31% | 10.02% |
Effective Tax Rate | - | - | 21.24% | - | 25.94% | - |
Revenue as Reported | 6,219 | 5,060 | 4,719 | 4,482 | 3,446 | 760.1 |
Advertising Expenses | - | 0.58 | 1.61 | 2.1 | 0.44 | 0.06 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.